Tag Archives: Congress

Congress, FDA Should Consider Tech Solutions for Safer Compounding

By Niels Erik Hansen Last fall’s deadly meningitis outbreak linked to contaminated steroid injections is a tragic reminder of the risk of errors inherent in manual pharmacy medication compounding. Unsanitary conditions at the Massachusetts compounding pharmacy that made the injections resulted in fungal contamination of the drugs. The resulting outbreak sickened nearly 700 people in […]
Posted in compliance, Guest Blog, healthcare, Manufacturing, Regulatory, Safety, Technology | Also tagged , , , | Leave a comment

Pharma Pricing Top Target for Medicare Cutbacks

In the dog-eat-dog world of federal deficit reduction, there seems to be one health-related spending cut with broad bi-partisan support:  require drug companies to give the federal government “a better deal on medications for low-income people on Medicare.” Nearly 70% of respondents back this strategy, according to a survey sponsored by the Kaiser Family Foundation […]
Posted in healthcare, pricing | Also tagged , , , , , , | 2 Comments

Pharma's Influence on the Super Committee: Is Cash Really King?

Three of the twelve appointees to the Joint Select Committee on Deficit Reduction (aka Super Committee) received over $300,000 in campaign contributions from pharmaceutical companies, according to Center for Responsive Politics data, and a MapLight analysis.
Posted in healthcare, leadership, Strategy | Also tagged , , , , , | 1 Comment

US Mid-Term Elections: What It Means for Pharma

Daily News Nugget US Mid-Term Elections:  What it Means for Pharma Drink up, even if it’s  only old wine in new bottles… Yesterday’s mid-term congressional poll barely changes the stakes for pharma in its pursuit of its US legislative and regulatory agenda.    The key message coming out of the results is stalemate on the […]
Posted in Op-Ed, Regulatory | Also tagged , , , , , , | 3 Comments

Health Reform Hazards: Steering Your Course Through the Rhetorical Shallows

Image by Getty Images via Dayli Crafting consensus legislation on health reform depends heavily on all parties understanding precisely the terms of the debate. With the two House and Senate bills now topping out at more than 4,000 text pages, prospects for even a basic awareness of the implications of this reform for big pharma […]
Posted in FDA, News | Also tagged , , , , , , | Leave a comment
  • Categories

  • Meta